Lifeward (LFWD) vs CollPlant Biotechnologies (OPHI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CollPlant Biotechnologies is the larger company by market cap ($9.6 million vs $8.0 million), about 1.2 times the size. Lifeward converts more of its revenue into profit, with a net margin of -90.4% versus -484.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFWD | OPHI |
|---|---|---|
| Share price | $2.80 | $3.13 |
| Market cap | $7.96M | $9.63M |
| 1-day change | -5.30% | -2.49% |
| YTD return | -59.52% | — |
| 1-year return | -55.42% | — |
| 5-year return | -97.53% | — |
| EPS (TTM) | $-13.15 | $-9.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $22.03M | $2.37M |
| Revenue growth (YoY) | -14.14% | +360.39% |
| Net income (latest FY) | $-19.91M | $-11.49M |
| Gross margin | 38.25% | 64.78% |
| Operating margin | -89.29% | -484.31% |
| Net margin | -90.38% | -484.56% |
| 52-week high | $9.61 | $22.50 |
| 52-week low | $2.67 | $2.64 |
| Distance from 52-week high | -70.83% | -86.09% |
| Analyst consensus | none | — |
| Avg. price target upside | +613.52% | — |
| Average volume | 12.40K | 385.37K |
| Shares outstanding | 2.84M | 3.08M |
| Employees | 81 | — |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Lifeward is more profitable, keeping -90.4 cents of every revenue dollar as net income versus -484.6 cents for CollPlant Biotechnologies.
- CollPlant Biotechnologies grew revenue faster in its latest fiscal year (+360.39% vs -14.14%).
About Lifeward
LFWD stock →Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke.
Health Care · Industrial Specialties · 81 employees
LFWD vs OPHI FAQ
Which is bigger, Lifeward or CollPlant Biotechnologies?
CollPlant Biotechnologies (OPHI) is larger, with a market capitalization of $9.63M compared with $7.96M for Lifeward (LFWD).
Are Lifeward and CollPlant Biotechnologies in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.